Gene therapy for ocular diseases meditated by ultrasound and microbubbles (Review)

Molecular Medicine Reports

Volumn 12, Issue 4, 2015, Pages 4803-4814

  Wan, Caifeng ^a   Li, Fenghua ^a   Li, Hongli ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Gene therapy; Microbubble; Ocular; Ultrasound

Indexed keywords

ECHO CONTRAST MEDIUM;

BLOOD RETINA BARRIER; CILIARY MUSCLE; CORNEA; ECHOGRAPHY; EXTRAOCULAR MUSCLE; EYE DISEASE; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; MICROBUBBLE; NONHUMAN; RETINA; RETINOBLASTOMA; REVIEW; ULTRASOUND TARGETED MICROBUBBLE DESTRUCTION; ANIMAL; DRUG DELIVERY SYSTEM; EYE DISEASES; GENETICS; PROCEDURES; ULTRASOUND;

ANIMALS; DRUG DELIVERY SYSTEMS; EYE DISEASES; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HUMANS; MICROBUBBLES; ULTRASONICS;

EID: 84940564068     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4054     Document Type: Review

References (78)

1. Surace EM and Auricchio A: Versatility of AAV vectors for retinal gene transfer. Vision Res 48: 353-359, 2008.
2. Zhang L, Li X, Zhao M, He P, Yu W, Dong J et al: Antisense oligonucleotide targeting c-fos mRNA limits retinal pigment epithelial cell proliferation; a key step in the progression of proliferative vitreoretinopathy. Exp Eye Res 83: 1405-1411, 2006.
3. Kuliszewski MA, Kobulnik J, Lindner JR, Stewart DJ and Leong-Poi H: Vascular gene transfer of SDF-1 promotes endo-thelial progenitor cell engraftment and enhances angiogenesis in ischemic muscle. Mol Ther 19: 895-902, 2011.
4. Li HL, Zheng XZ, Wang HP, Li F, Wu Y and Du LF: Ultrasound-targeted microbubble destruction enhances AAV-mediated gene transfection in human RPE cells in vitro and rat retina in vivo. Gene Ther 16: 1146-1153, 2009.
5. Zhigang W, Zhiyu L, Haitao R, et al: Ultrasound-mediated microbubble destruction enhances VEGF gene delivery to the infarcted myocardium in rats. Clin Imaging 28: 395-398, 2004.
6. Zhang Q, Wang Z, Ran H, et al: Enhanced gene delivery into skeletal muscles with ultrasound and microbubble techniques. Acad Radiol 13: 363-367, 2006.
7. Ren JL, Wang ZG, Zhang Y, et al: Transfection effciency of TDL compound in HUVEC enhanced by ultrasound-targeted micro-bubble destruction. Ultrasound Med Biol 34: 1857-1867, 2008.
8. Chen S, Shimoda M, Chen J and Grayburn PA: Stimulation of adult resident cardiac progenitor cells by durable myocardial expression of thymosin beta 4 with ultrasound-targeted micro-bubble delivery. Gene Ther 20: 225-233, 2013.
9. Sonoda S, Tachibana K, Uchino E, et al: Gene transfer to corneal epithelium and keratocytes mediated by ultrasound with micro-bubbles. Invest Ophthalmol Vis Sci 47: 558-564, 2006.
10. Chen S, Shimoda M, Wang MY, et al: Regeneration of pancreatic islets in vivo by ultrasound-targeted gene therapy. Gene Ther 17: 1411-1420, 2010.
11. Li HL, Zheng XZ, Wang H P, Li F, Wu Y and Du LF: Ultrasound-targeted microbubble destruction enhances AAV-mediated gene transfection in human RPE cells in vitro and rat retina in vivo. Gene Ther 16: 1146-1153, 2009.
12. Xie W, Liu S, Su H, Wang Z, Zheng Y and Fu Y: Ultrasound microbubbles enhance recombinant adeno-associated virus vector delivery to retinal ganglion cells in vivo. Acad Radiol 17: 1242-1248, 2010.
13. Sonoda S, Tachibana K, Yamashita T, et al: Selective gene transfer to the retina using intravitreal ultrasound irradiation. J Ophthalmol 2012: 412752, 2012.
14. Hippert C, Ibanes S, Serratrice N, et al: Corneal transduction by intra-stromal injection of A AV vectors in vivo in the mouse and ex vivo in human explants. PLoS One 7: e35318, 2012.
15. Kamata Y, Okuyama T, Kosuga M, et al: Adenovirus-mediated gene therapy for corneal clouding in mice with mucopolysac-charidosis type VII. Mol Ther 4: 307-312, 2001.
16. Klausner EA, Peer D, Chapman RL, Multack RF and Andurkar SV: Corneal gene therapy. J Control Release 124: 107-133, 2007.
17. Liu HA, Liu YL, Ma ZZ, Wang JC and Zhang Q: A lipid nanoparticle system improves siRNA effcacy in RPE cells and a laser-induced murine CNV model. Invest Ophthalmol Vis Sci 52: 4789-4794, 2011.
18. Shafaa MW, El Shazly LH, El Shazly AH, El gohary AA, El hossary GG: Effcacy of topically applied liposome-bound tetracycline in the treatment of dry eye model. Vet Ophthalmol 14: 18-25, 2011.
19. Dalkara D, Kolstad KD, Caporale N, et al: Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous. Mol Ther 17: 2096-2102, 2009.
20. Peyman GA, Lad EM and Moshfeghi DM: Intravitreal injection of therapeutic agents. Retina 29: 875-912, 2009.
21. Wu H and Chen TC: The effects of intravitreal ophthalmic medications on intraocular pressure. Semin Ophthalmol 24: 100-105, 2009.
22. Peeters L, Lentacker I, Vandenbroucke RE, et al: Can ultrasound solve the transport barrier of the neural retina? Pharm Res 25: 2657-2665, 2008.
23. Du J, Shi QS, Sun Y, et al: Enhanced delivery of monomethoxypoly(ethylene glycol)-poly(lactic-co-glycolic acid)-poly l-lysine nanoparticles loading platelet-derived growth factor BB small interfering RNA by ultrasound and/or micro-bubbles to rat retinal pigment epithelium cells. J Gene Med 13: 312-323, 2011.
24. Bishop P: The biochemical structure of mammalian vitreous. Eye (Lond) 10 (Pt 6): 664-670, 1996.
25. Peeters L, Sanders NN, Braeckmans K, et al: Vitreous: a barrier to nonviral ocular gene therapy. Invest Ophthalmol Vis Sci 46: 3553-3561, 2005.
26. Nishikawa M and Huang L: Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther 12: 861-870, 2001.
27. Manickan E, Smith JS, Tian J, et al: Rapid Kupffer cell death after intravenous injection of adenovirus vectors. Mol Ther 13: 108-117, 2006.
28. Igarashi T, Miyake N, Fujimoto C, et al: Adeno-associated virus type 8 vector-mediated expression of siRNA targeting vascular endothelial growth factor effciently inhibits neovascularization in a murine choroidal neovascularization model. Mol Vis 20: 488-496, 2014.
29. Huang C, Cen L P, Liu L, et al: Adeno-associated virus-mediated expression of growth-associated protein-43 aggravates retinal ganglion cell death in experimental chronic glaucomatous injury. Mol Vis 19: 1422-1432, 2013.
30. Ikeda Y, Yonemitsu Y, Miyazaki M, et al: Acute toxicity study of a simian immunodefciency virus-based lentiviral vector for retinal gene transfer in nonhuman primates. Hum Gene Ther 20: 943-954, 2009.
31. Cavazzana-Calvo M and Fischer A: Gene therapy for severe combined immunodefciency: are we there yet? J Clin Invest 117: 1456-1465, 2007.
32. Wang Z, Storb R, Lee D, et al: Immune responses to A AV in canine muscle monitored by cellular assays and noninvasive imaging. Mol Ther 18: 617-624, 2010.
33. Wilson JM: Lessons learned from the gene therapy trial for ornithine transcarbamylase defciency. Mol Genet Metab 96: 151-157, 2009.
34. Wu J, Zhang S, Wu X, et al: Enhanced transduction and improved photoreceptor survival of retinal degeneration by the combinatorial use of rAAV2 with a lower dose of adenovirus. Vision Res 48: 1648-1654, 2008.
35. Provost N, Le Meur G, Weber M, et al: Biodistribution of rAAV vectors following intraocular administration: evidence for the presence and persistence of vector DNA in the optic nerve and in the brain. Mol Ther 11: 275-283, 2005.
36. Park HJ, Yang F and Cho SW: Nonviral delivery of genetic medicine for therapeutic angiogenesis. Adv Drug Deliv Rev 64: 40-52, 2012.
37. Nayerossadat N, Maedeh T and Ali PA: Viral and nonviral delivery systems for gene delivery. Adv Biomed Res 1: 27, 2012.
38. Bloquel C, Bourges JL, Touchard E, Berdugo M, BenEzra D and Behar-Cohen F: Non-viral ocular gene therapy: potential ocular therapeutic avenues. Adv Drug Deliv Rev 58: 1224-1242, 2006.
39. Thrimawithana TR, Young S, Bunt CR, Green C and Alany RG: Drug delivery to the posterior segment of the eye. Drug Discov Today 16: 270-277, 2011.
40. Gaudana R, Ananthula HK, Parenky A and Mitra AK: Ocular drug delivery. AAPS J 12: 348-360, 2010.
41. Jayaraman MS, Bharali DJ, Sudha T and Mousa SA: Nano chitosan peptide as a potential therapeutic carrier for retinal delivery to treat age-related macular degeneration. Mol Vis 18: 2300-2308, 2012.
42. Zhou H, Yang L, Li H, et al: Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells. Int J Nanomedicine 7: 4649-4660, 2012.
43. Bainbridge J W, Tan MH and Ali RR: Gene therapy progress and prospects: the eye. Gene Ther 13: 1191-1197, 2006.
44. Han S, Mahato RI, Sung YK and Kim SW: Development of biomaterials for gene therapy. Mol Ther 2: 302-317, 2000.
45. Yamashita T, Sonoda S, Suzuki R, et al: A novel bubble liposome and ultrasound-mediated gene transfer to ocular surface: RC-1 cells in vitro and conjunctiva in vivo. Exp Eye Res 85: 741-748, 2007.
46. Luo J, Zhou X, Diao L and Wang Z: Experimental research on wild-type p53 plasmid transfected into retinoblastoma cells and tissues using an ultrasound microbubble intensifer. J Int Med Res 38: 1005-1015, 2010.
47. Daigeler A, Chromik AM, Haendschke K, et al: Synergistic effects of sonoporation and taurolidin/TRAIL on apoptosis in human fbrosarcoma. Ultrasound Med Biol 36: 1893-1906, 2010.
48. Lin C Y, Liu TM, Chen CY, et al: Quantitative and qualitative investigation into the impact of focused ultrasound with micro-bubbles on the triggered release of nanoparticles from vasculature in mouse tumors. J Control Release 146: 291-298, 2010.
49. Wang Y, Zhou J, Zhang Y, Wang X and Chen J: Delivery of TFPI-2 using SonoVue and adenovirus results in the suppression of thrombosis and arterial re-stenosis. Exp Biol Med (Maywood) 235: 1072-1081, 2010.
50. Sirsi SR and Borden MA: Advances in ultrasound mediated gene therapy using microbubble contrast agents. Theranostics 2: 1208-1222, 2012.
51. Liang HD, Tang J and Halliwell M: Sonoporation, drug delivery and gene therapy. Proc Inst Mech Eng H 224: 343-361, 2010.
52. Lawrie A, Brisken A F, Francis SE, et al: Ultrasound enhances reporter gene expression after transfection of vascular cells in vitro. Circulation 99: 2617-2620, 1999.
53. Taniyama Y, Tachibana K, Hiraoka K, et al: Development of safe and effcient novel nonviral gene transfer using ultrasound: enhancement of transfection effciency of naked plasmid DNA in skeletal muscle. Gene Ther 9: 372-380, 2002.
54. Zhou Y, Yang K, Cui J, Ye JY and Deng CX: Controlled permeation of cell membrane by single bubble acoustic cavi-tation. J Control Release 157: 103-111, 2012.
55. Chen H, Kreider W, Brayman AA, Bailey MR and Matula TJ: Blood vessel deformations on microsecond time scales by ultrasonic cavitation. Phys Rev Lett 106: 034301, 2011.
56. Hauser J, Ellisman M, Steinau HU, Stefan E, Dudda M and Hauser M: Ultrasound enhanced endocytotic activity of human fbroblasts. Ultrasound Med Biol 35: 2084-2092, 2009.
57. Li W, Liu S, Ren J, Xiong H, Yan X and Wang Z: Gene transfection to retinal ganglion cells mediated by ultrasound microbubbles in vitro. Acad Radiol 16: 1086-1094, 2009.
58. Zhou XY, Liao Q, Pu YM, et al: Ultrasound-mediated micro-bubble delivery of pigment epithelium-derived factor gene into retina inhibits choroidal neovascularization. Chin Med J (Engl) 122: 2711-2717, 2009.
59. Lee SY, Huh MS, Lee S, et al: Stability and cellular uptake of polymerized siRNA (poly-siRNA)/polyethylenimine (PEI) complexes for effcient gene silencing. J Control Release 141: 339-346, 2010.
60. Howard CM, Forsberg F, Minimo C, Liu JB, Merton DA and Claudio PP: Ultrasound guided site specifc gene delivery system using adenoviral vectors and commercial ultrasound contrast agents. J Cell Physiol 209: 413-421, 2006.
61. Geers B, Lentacker I, Alonso A, et al: Elucidating the mechanisms behind sonoporation with adeno-associated virus-loaded microbubbles. Mol Pharm 8: 2244-2251, 2011.
62. Li F, Jin L, Wang H, et al: The dual effect of ultrasound-targeted microbubble destruction in mediating recombinant adeno-asso-ciated virus delivery in renal cell carcinoma: transfection enhancement and tumor inhibition. J Gene Med 16: 28-39, 2014.
63. Mueller C and Flotte TR: Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther 15: 858-863, 2008.
64. Zheng X, Du L, Wang H and Gu Q: A novel approach to attenuate proliferative vitreoretinopathy using ultrasound-targeted microbubble destruction and recombinant adeno-associated virus-mediated RNA interference targeting transforming growth factor-beta2 and platelet-derived growth factor-B. J Gene Med 14: 339-347, 2012.
65. Zheng XZ, Wu Y, Li HL, Du LF, Wang HP and Gu Q: Comparative analysis of the effects of ultrasound-targeted microbubble destruction on recombinant adeno-associated virus-and plasmid-mediated transgene expression in human retinal pigment epithelium cells. Mol Med Rep 2: 937-942, 2009.
66. Müller OJ, Schinkel S, Kleinschmidt JA, Katus HA and Bekeredjian R: Augmentation of AAV-mediated cardiac gene transfer after systemic administration in adult rats. Gene Ther 15: 1558-1565, 2008.
67. Jin LF, Li F, Wang HP, Wei F, Qin P and Du LF: Ultrasound targeted microbubble destruction stimulates cellular endocytosis in facilitation of adeno-associated virus delivery. Int J Mol Sci 14: 9737-9750, 2013.
68. van Wamel A, Kooiman K, Harteveld M, et al: Vibrating micro-bubbles poking individual cells: drug transfer into cells via sonoporation. J Control Release 112: 149-155, 2006.
69. Sorace AG, Warram JM, Umphrey H and Hoyt K: Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer. J Drug Target 20: 43-54, 2012.
70. Heath CH, Sorace A, Knowles J, Rosenthal E and Hoyt K: Microbubble therapy enhances anti-tumor properties of cisplatin and cetuximab in vitro and in vivo. Otolaryngol Head Neck Surg 146: 938-945, 2012.
71. Lee NG, Berry JL, Lee TC, et al: Sonoporation enhances chemotherapeutic effcacy in retinoblastoma cells in vitro. Invest Ophthalmol Vis Sci 52: 3868-3873, 2011.
72. Zheng MM, Zhou XY, Wang LP and Wang ZG: Experimental research of RB94 gene transfection into retinoblastoma cells using ultrasound-targeted microbubble destruction. Ultrasound Med Biol 38: 1058-1066, 2012.
73. Campbell M, Nguyen AT, Kiang AS, et al: An experimental platform for systemic drug delivery to the retina. Proc Natl Acad Sci USA 106: 17817-17822, 2009.
74. Baseri B, Choi JJ, Tung YS and Konofagou EE: Multi-modality safety assessment of blood-brain barrier opening using focused ultrasound and definity microbubbles: a short-term study. Ultrasound Med Biol 36: 1445-1459, 2010.
75. Liu HL, Hua MY, Chen PY, et al: Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology 255: 415-425, 2010.
76. Park J, Zhang Y, Vykhodtseva N, Akula JD and McDannold NJ: Targeted and reversible blood-retinal barrier disruption via focused ultrasound and microbubbles. PLoS One 7: e42754, 2012.
77. Sheikov N, McDannold N, Sharma S and Hynynen K: Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endo-thelium. Ultrasound Med Biol 34: 1093-1104, 2008.
78. Kowalczuk L, Boudinet M, El Sanharawi M, et al: In vivo gene transfer into the ocular ciliary muscle mediated by ultrasound and microbubbles. Ultrasound Med Biol 37: 1814-1827, 2011.